[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Nuclear Medicine Market - Global Outlook and Forecast 2021-2027

March 2021 | 108 pages | ID: NE7B585A774AEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Nuclear Medicine in Global, including the following market information:

Global Nuclear Medicine Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Nuclear Medicine market was valued at 5929.5 million in 2020 and is projected to reach US$ 7796.2 million by 2027, at a CAGR of 7.1% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nuclear Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Nuclear Medicine Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Nuclear Medicine Market Segment Percentages, By Type, 2020 (%)
  • Tc-99
  • I-123/131
  • In-111
  • Xe-133
  • Th-201
  • Ga-67
  • Others
China Nuclear Medicine Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Nuclear Medicine Market Segment Percentages, By Application, 2020 (%)
  • Diagnostic
  • Therapeutic
Global Nuclear Medicine Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Nuclear Medicine Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Nuclear Medicine Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Nuclear Medicine Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • GE Healthcare
  • Bracco Imaging
  • Mallinckrodt
  • Lantheus Medical Imaging
  • Bayer
  • Triad Isotopes
  • Nordion
  • Jubilant Pharma
  • Eli Lilly
  • SIEMENS
  • China Isotope & Radiation
  • Dongcheng
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Nuclear Medicine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Nuclear Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NUCLEAR MEDICINE OVERALL MARKET SIZE

2.1 Global Nuclear Medicine Market Size: 2021 VS 2027
2.2 Global Nuclear Medicine Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Nuclear Medicine Players in Global Market
3.2 Top Global Nuclear Medicine Companies Ranked by Revenue
3.3 Global Nuclear Medicine Revenue by Companies
3.4 Top 3 and Top 5 Nuclear Medicine Companies in Global Market, by Revenue in 2020
3.5 Global Companies Nuclear Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nuclear Medicine Players in Global Market
  3.6.1 List of Global Tier 1 Nuclear Medicine Companies
  3.6.2 List of Global Tier 2 and Tier 3 Nuclear Medicine Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Nuclear Medicine Market Size Markets, 2021 & 2027
  4.1.2 Tc-99
  4.1.3 I-123/131
  4.1.4 In-111
  4.1.5 Xe-133
  4.1.6 Th-201
  4.1.7 Ga-67
  4.1.8 Others
4.2 By Type - Global Nuclear Medicine Revenue & Forecasts
  4.2.1 By Type - Global Nuclear Medicine Revenue, 2016-2021
  4.2.2 By Type - Global Nuclear Medicine Revenue, 2022-2027
  4.2.3 By Type - Global Nuclear Medicine Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Nuclear Medicine Market Size, 2021 & 2027
  5.1.2 Diagnostic
  5.1.3 Therapeutic
5.2 By Application - Global Nuclear Medicine Revenue & Forecasts
  5.2.1 By Application - Global Nuclear Medicine Revenue, 2016-2021
  5.2.2 By Application - Global Nuclear Medicine Revenue, 2022-2027
  5.2.3 By Application - Global Nuclear Medicine Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Nuclear Medicine Market Size, 2021 & 2027
6.2 By Region - Global Nuclear Medicine Revenue & Forecasts
  6.2.1 By Region - Global Nuclear Medicine Revenue, 2016-2021
  6.2.2 By Region - Global Nuclear Medicine Revenue, 2022-2027
  6.2.3 By Region - Global Nuclear Medicine Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Nuclear Medicine Revenue, 2016-2027
  6.3.2 US Nuclear Medicine Market Size, 2016-2027
  6.3.3 Canada Nuclear Medicine Market Size, 2016-2027
  6.3.4 Mexico Nuclear Medicine Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Nuclear Medicine Revenue, 2016-2027
  6.4.2 Germany Nuclear Medicine Market Size, 2016-2027
  6.4.3 France Nuclear Medicine Market Size, 2016-2027
  6.4.4 U.K. Nuclear Medicine Market Size, 2016-2027
  6.4.5 Italy Nuclear Medicine Market Size, 2016-2027
  6.4.6 Russia Nuclear Medicine Market Size, 2016-2027
  6.4.7 Nordic Countries Nuclear Medicine Market Size, 2016-2027
  6.4.8 Benelux Nuclear Medicine Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Nuclear Medicine Revenue, 2016-2027
  6.5.2 China Nuclear Medicine Market Size, 2016-2027
  6.5.3 Japan Nuclear Medicine Market Size, 2016-2027
  6.5.4 South Korea Nuclear Medicine Market Size, 2016-2027
  6.5.5 Southeast Asia Nuclear Medicine Market Size, 2016-2027
  6.5.6 India Nuclear Medicine Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Nuclear Medicine Revenue, 2016-2027
  6.6.2 Brazil Nuclear Medicine Market Size, 2016-2027
  6.6.3 Argentina Nuclear Medicine Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Nuclear Medicine Revenue, 2016-2027
  6.7.2 Turkey Nuclear Medicine Market Size, 2016-2027
  6.7.3 Israel Nuclear Medicine Market Size, 2016-2027
  6.7.4 Saudi Arabia Nuclear Medicine Market Size, 2016-2027
  6.7.5 UAE Nuclear Medicine Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 GE Healthcare
  7.1.1 GE Healthcare Corporate Summary
  7.1.2 GE Healthcare Business Overview
  7.1.3 GE Healthcare Nuclear Medicine Major Product Offerings
  7.1.4 GE Healthcare Nuclear Medicine Revenue in Global (2016-2021)
  7.1.5 GE Healthcare Key News
7.2 Bracco Imaging
  7.2.1 Bracco Imaging Corporate Summary
  7.2.2 Bracco Imaging Business Overview
  7.2.3 Bracco Imaging Nuclear Medicine Major Product Offerings
  7.2.4 Bracco Imaging Nuclear Medicine Revenue in Global (2016-2021)
  7.2.5 Bracco Imaging Key News
7.3 Mallinckrodt
  7.3.1 Mallinckrodt Corporate Summary
  7.3.2 Mallinckrodt Business Overview
  7.3.3 Mallinckrodt Nuclear Medicine Major Product Offerings
  7.3.4 Mallinckrodt Nuclear Medicine Revenue in Global (2016-2021)
  7.3.5 Mallinckrodt Key News
7.4 Lantheus Medical Imaging
  7.4.1 Lantheus Medical Imaging Corporate Summary
  7.4.2 Lantheus Medical Imaging Business Overview
  7.4.3 Lantheus Medical Imaging Nuclear Medicine Major Product Offerings
  7.4.4 Lantheus Medical Imaging Nuclear Medicine Revenue in Global (2016-2021)
  7.4.5 Lantheus Medical Imaging Key News
7.5 Bayer
  7.5.1 Bayer Corporate Summary
  7.5.2 Bayer Business Overview
  7.5.3 Bayer Nuclear Medicine Major Product Offerings
  7.5.4 Bayer Nuclear Medicine Revenue in Global (2016-2021)
  7.5.5 Bayer Key News
7.6 Triad Isotopes
  7.6.1 Triad Isotopes Corporate Summary
  7.6.2 Triad Isotopes Business Overview
  7.6.3 Triad Isotopes Nuclear Medicine Major Product Offerings
  7.6.4 Triad Isotopes Nuclear Medicine Revenue in Global (2016-2021)
  7.6.5 Triad Isotopes Key News
7.7 Nordion
  7.7.1 Nordion Corporate Summary
  7.7.2 Nordion Business Overview
  7.7.3 Nordion Nuclear Medicine Major Product Offerings
  7.4.4 Nordion Nuclear Medicine Revenue in Global (2016-2021)
  7.7.5 Nordion Key News
7.8 Jubilant Pharma
  7.8.1 Jubilant Pharma Corporate Summary
  7.8.2 Jubilant Pharma Business Overview
  7.8.3 Jubilant Pharma Nuclear Medicine Major Product Offerings
  7.8.4 Jubilant Pharma Nuclear Medicine Revenue in Global (2016-2021)
  7.8.5 Jubilant Pharma Key News
7.9 Eli Lilly
  7.9.1 Eli Lilly Corporate Summary
  7.9.2 Eli Lilly Business Overview
  7.9.3 Eli Lilly Nuclear Medicine Major Product Offerings
  7.9.4 Eli Lilly Nuclear Medicine Revenue in Global (2016-2021)
  7.9.5 Eli Lilly Key News
7.10 SIEMENS
  7.10.1 SIEMENS Corporate Summary
  7.10.2 SIEMENS Business Overview
  7.10.3 SIEMENS Nuclear Medicine Major Product Offerings
  7.10.4 SIEMENS Nuclear Medicine Revenue in Global (2016-2021)
  7.10.5 SIEMENS Key News
7.11 China Isotope & Radiation
  7.11.1 China Isotope & Radiation Corporate Summary
  7.11.2 China Isotope & Radiation Business Overview
  7.11.3 China Isotope & Radiation Nuclear Medicine Major Product Offerings
  7.11.4 China Isotope & Radiation Nuclear Medicine Revenue in Global (2016-2021)
  7.11.5 China Isotope & Radiation Key News
7.12 Dongcheng
  7.12.1 Dongcheng Corporate Summary
  7.12.2 Dongcheng Business Overview
  7.12.3 Dongcheng Nuclear Medicine Major Product Offerings
  7.12.4 Dongcheng Nuclear Medicine Revenue in Global (2016-2021)
  7.12.5 Dongcheng Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Nuclear Medicine Market Opportunities & Trends in Global Market
Table 2. Nuclear Medicine Market Drivers in Global Market
Table 3. Nuclear Medicine Market Restraints in Global Market
Table 4. Key Players of Nuclear Medicine in Global Market
Table 5. Top Nuclear Medicine Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Nuclear Medicine Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Nuclear Medicine Revenue Share by Companies, 2016-2021
Table 8. Global Companies Nuclear Medicine Product Type
Table 9. List of Global Tier 1 Nuclear Medicine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nuclear Medicine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Nuclear Medicine Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Nuclear Medicine Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Nuclear Medicine Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Nuclear Medicine Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Nuclear Medicine Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Nuclear Medicine Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Nuclear Medicine Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Nuclear Medicine Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Nuclear Medicine Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Nuclear Medicine Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Nuclear Medicine Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Nuclear Medicine Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Nuclear Medicine Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Nuclear Medicine Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Nuclear Medicine Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Nuclear Medicine Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Nuclear Medicine Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Nuclear Medicine Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Nuclear Medicine Revenue, (US$, Mn), 2022-2027
Table 30. GE Healthcare Corporate Summary
Table 31. GE Healthcare Nuclear Medicine Product Offerings
Table 32. GE Healthcare Nuclear Medicine Revenue (US$, Mn), (2016-2021)
Table 33. Bracco Imaging Corporate Summary
Table 34. Bracco Imaging Nuclear Medicine Product Offerings
Table 35. Bracco Imaging Nuclear Medicine Revenue (US$, Mn), (2016-2021)
Table 36. Mallinckrodt Corporate Summary
Table 37. Mallinckrodt Nuclear Medicine Product Offerings
Table 38. Mallinckrodt Nuclear Medicine Revenue (US$, Mn), (2016-2021)
Table 39. Lantheus Medical Imaging Corporate Summary
Table 40. Lantheus Medical Imaging Nuclear Medicine Product Offerings
Table 41. Lantheus Medical Imaging Nuclear Medicine Revenue (US$, Mn), (2016-2021)
Table 42. Bayer Corporate Summary
Table 43. Bayer Nuclear Medicine Product Offerings
Table 44. Bayer Nuclear Medicine Revenue (US$, Mn), (2016-2021)
Table 45. Triad Isotopes Corporate Summary
Table 46. Triad Isotopes Nuclear Medicine Product Offerings
Table 47. Triad Isotopes Nuclear Medicine Revenue (US$, Mn), (2016-2021)
Table 48. Nordion Corporate Summary
Table 49. Nordion Nuclear Medicine Product Offerings
Table 50. Nordion Nuclear Medicine Revenue (US$, Mn), (2016-2021)
Table 51. Jubilant Pharma Corporate Summary
Table 52. Jubilant Pharma Nuclear Medicine Product Offerings
Table 53. Jubilant Pharma Nuclear Medicine Revenue (US$, Mn), (2016-2021)
Table 54. Eli Lilly Corporate Summary
Table 55. Eli Lilly Nuclear Medicine Product Offerings
Table 56. Eli Lilly Nuclear Medicine Revenue (US$, Mn), (2016-2021)
Table 57. SIEMENS Corporate Summary
Table 58. SIEMENS Nuclear Medicine Product Offerings
Table 59. SIEMENS Nuclear Medicine Revenue (US$, Mn), (2016-2021)
Table 60. China Isotope & Radiation Corporate Summary
Table 61. China Isotope & Radiation Nuclear Medicine Product Offerings
Table 62. China Isotope & Radiation Nuclear Medicine Revenue (US$, Mn), (2016-2021)
Table 63. Dongcheng Corporate Summary
Table 64. Dongcheng Nuclear Medicine Product Offerings
Table 65. Dongcheng Nuclear Medicine Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Nuclear Medicine Segment by Type
Figure 2. Nuclear Medicine Segment by Application
Figure 3. Global Nuclear Medicine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Nuclear Medicine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Nuclear Medicine Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Nuclear Medicine Revenue in 2020
Figure 8. By Type - Global Nuclear Medicine Revenue Market Share, 2016-2027
Figure 9. By Application - Global Nuclear Medicine Revenue Market Share, 2016-2027
Figure 10. By Region - Global Nuclear Medicine Revenue Market Share, 2016-2027
Figure 11. By Country - North America Nuclear Medicine Revenue Market Share, 2016-2027
Figure 12. US Nuclear Medicine Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Nuclear Medicine Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Nuclear Medicine Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Nuclear Medicine Revenue Market Share, 2016-2027
Figure 16. Germany Nuclear Medicine Revenue, (US$, Mn), 2016-2027
Figure 17. France Nuclear Medicine Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Nuclear Medicine Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Nuclear Medicine Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Nuclear Medicine Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Nuclear Medicine Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Nuclear Medicine Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Nuclear Medicine Revenue Market Share, 2016-2027
Figure 24. China Nuclear Medicine Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Nuclear Medicine Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Nuclear Medicine Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Nuclear Medicine Revenue, (US$, Mn), 2016-2027
Figure 28. India Nuclear Medicine Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Nuclear Medicine Revenue Market Share, 2016-2027
Figure 30. Brazil Nuclear Medicine Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Nuclear Medicine Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Nuclear Medicine Revenue Market Share, 2016-2027
Figure 33. Turkey Nuclear Medicine Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Nuclear Medicine Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Nuclear Medicine Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Nuclear Medicine Revenue, (US$, Mn), 2016-2027
Figure 37. GE Healthcare Nuclear Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Bracco Imaging Nuclear Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Mallinckrodt Nuclear Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Lantheus Medical Imaging Nuclear Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Bayer Nuclear Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Triad Isotopes Nuclear Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Nordion Nuclear Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Jubilant Pharma Nuclear Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Eli Lilly Nuclear Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. SIEMENS Nuclear Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. China Isotope & Radiation Nuclear Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications